Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company
Vaccines form an important part of the combat against the current COVID-19 health crisis. Getting a range of effective vaccines to the market quickly will be essential if we are
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation and a world leader in vaccine and antiviral testing using human challenge clinical trials, has confirmed that, following
Data from therapy development, especially those involving cells, can quickly mushroom into an unmanageable pile in the lab — what happens when you move to the clinic? We sat down
Design of Experiments (DoE), introduced in the 1920s, is a valuable modelling tool to support in amongst the systematic development of (bio)pharmaceutical products, processes and analytical methods. Especially in combination
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that hVIVO,
Human challenge studies provide more valuable information than animal challenge studies, which produce results that must be extrapolated in order to determine the impact on humans. They also allow for
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company
It’s been over a year since my office shut down. Over a year since I went to a bar, a fitness class, a movie theater, a concert, a Knicks game, or
Regulators around the globe have reviewed marketing authorisation applications (MAAs) for COVID-19 vaccines and treatments at record speed. One of the tools they used to speed the review cycle is
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
